candesartan has been researched along with Hypertrophy, Right Ventricular in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, M | 1 |
| Takeishi, Y | 1 |
| Nakada, S | 1 |
| Miyamoto, T | 1 |
| Tsunoda, Y | 1 |
| Takahashi, H | 1 |
| Kubota, I | 1 |
| Tomoike, H | 1 |
| Kishi, K | 1 |
| Jin, D | 1 |
| Takai, S | 1 |
| Muramatsu, M | 1 |
| Katayama, H | 1 |
| Tamai, H | 1 |
| Miyazaki, M | 1 |
2 other studies available for candesartan and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Long-term treatment with angiotensin II type 1 receptor antagonist, CV-11974, restores beta-catenin mRNA expression in volume-overloaded rabbit hearts.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; beta Catenin; Bi | 2002 |
Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; | 2006 |